As of 2026-01-17, the Relative Valuation of Bright Minds Biosciences Inc (DRUG.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 115.80 CAD, the upside of Bright Minds Biosciences Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2026-01-02 | -101.16 |
| 2025-12-31 | -96.47 |
| 2025-12-30 | -93.72 |
| 2025-12-29 | -96.72 |
| 2025-12-24 | -103.08 |
| 2025-12-23 | -100.95 |
| 2025-12-22 | -99.79 |
| 2025-12-19 | -101.34 |
| 2025-12-18 | -96.12 |
| 2025-12-17 | -106.93 |
| 2025-12-16 | -115.21 |
| 2025-12-15 | -103.38 |
| 2025-12-12 | -101.23 |
| 2025-12-11 | -107.21 |
| 2025-12-10 | -102.60 |
| 2025-12-09 | -94.58 |
| 2025-12-08 | -99.89 |
| 2025-12-05 | -93.03 |
| 2025-12-04 | -87.36 |
| 2025-12-03 | -88.63 |
| 2025-12-02 | -86.59 |
| 2025-12-01 | -86.07 |
| 2025-11-28 | -83.48 |
| 2025-11-26 | -80.18 |
| 2025-11-25 | -74.69 |
| 2025-11-24 | -74.69 |
| 2025-11-21 | -72.03 |
| 2025-11-20 | -70.47 |
| 2025-11-19 | -71.63 |
| 2025-11-18 | -70.61 |
| 2025-11-17 | -70.75 |
| 2025-11-14 | -71.01 |
| 2025-11-13 | -71.82 |
| 2025-11-11 | -70.97 |
| 2025-11-10 | -72.69 |
| 2025-11-04 | -63.61 |
| 2025-10-31 | -67.33 |
| 2025-10-30 | -64.49 |
| 2025-10-29 | -67.90 |
| 2025-10-28 | -71.22 |
| 2025-10-27 | -71.23 |
| 2025-10-24 | -75.51 |
| 2025-10-23 | -74.91 |
| 2025-10-22 | -74.12 |
| 2025-10-21 | -82.55 |
| 2025-10-20 | -81.20 |
| 2025-10-16 | -84.30 |